CellCarta Forms Global Digital Pathology and AI Consortium
Jul 16, 2026
Healthcare
CellCarta Adds Tempus to Companion Diagnostics Lab Network
August 06, 2026
CellCarta has added Tempus as the second commercial laboratory partner in its CDx Commercialization Lab Network to support oncology companion diagnostics in U.S. practice.
CellCarta has added Tempus as the second commercial laboratory partner in its CDx Commercialization Lab Network, the company announced in a press release.
The agreement adds Tempus to a network built to support oncology companion diagnostics for biopharma sponsors. CellCarta said it will develop and validate the companion diagnostic, generate analytical and clinical evidence, support regulatory submissions, and perform centralized immunohistochemistry and tissue testing.
Through Tempus Hub, healthcare providers can order tests, sample testing is routed to CellCarta, and results are sent back to ordering providers. Tempus joins Sonic Healthcare USA as the second member of the network.
CellCarta said the network is part of its CDx Accelerator Model, which covers four stages: Build, Validate, Launch, and Transfer. After approval, CellCarta activates commercial laboratory partners to support launch plans for centralized companion diagnostics.
We hope you enjoyed this article.
Consider subscribing to one of our newsletters like Enterprise AI Brief, Life AI Weekly or Daily AI Brief.
Also, consider following us on social media:
More from: Enterprise
08/06
Chainsight Partners With Anthropic for Supply Chain AI Services
08/06
Acrab Raises US$130 Million for Agentic AI Compute Platform
08/06
AssetBuilt Launches AI Platform for Industrial Asset Assessments
08/06
ClaimsBridge Gets Eir Partners Investment and Buys DialysisPPO
08/05
Schreiber Foods and Ascendion Partner on Agentic AI for Operations
More from: Life Sciences
08/06
Hyro Adds Healthcare AI Agents to ServiceNow Workflows
08/06
Aqurio Offers SmartAnalytics Trial for Healthcare Patient Access Analysis
08/06
Apella Studies Find Higher Surgical Volume at Houston Methodist
08/06
GenScript and Tamarind Bio Connect AI Molecular Design With Lab Validation
08/06
Olio Labs Says AI Platform Predicts Clinical Trial Outcomes From Animal Studies
Subscribe to Life AI Weekly
Weekly coverage of AI applications in healthcare, drug development, biotechnology research, and genomics breakthroughs.
Market report
.png)
2025 Generative AI in Professional Services Report
Thomson Reuters
This report by Thomson Reuters explores the integration and impact of generative AI technologies, such as ChatGPT and Microsoft Copilot, within the professional services sector. It highlights the growing adoption of GenAI tools across industries like legal, tax, accounting, and government, and discusses the challenges and opportunities these technologies present. The report also examines professionals' perceptions of GenAI and the need for strategic integration to maximize its value.
Read more